Vaccine trial successes boosted Moderna and Merck, while investors awaited Fed minutes amid geopolitical uncertainty in the Middle East and disappointing OpenAI results.

The entities involved

• Moderna →

  American biotechnology company

  • Biotech and pharmaceutical companies in Greater Boston are seeing strategic investments, talent movement, and antibody development advances.Tue 13:27
  • Moderna and BioNTech are recognized as leaders in the personalized cancer vaccine space.Sun 19:37
• Merck →

  public company in Indonesia

  • The Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.Tue 00:53
  • Moderna and Merck reported a landmark result from their melanoma study, while SanDisk and Dell were discussed in stock market analysis.Sun 06:35
• OpenAI →

  American artificial intelligence research organization

  • CoreWeave and OpenAI face bearish sentiment due to disappointing revenue and insufficient AI revenue to support CAPEX.Tue 14:41
  • An OpenAI engineer, Abdulrahman Alfozan, is advising Saudi organizations, with connections traced to Riyadh and Raed Ventures.Tue 09:13
• Federal Open Market Committee →

  committee of the United States Federal Reserve

  • Costco is positioned to withstand the current high-rate economic environment.Sat 03:10
  • Fed rate decisions are expected to influence stock movement, and real estate attractiveness increases when Treasury yields fall.Fri 00:37

Related events

• The White House announced new tariffs on Canadian imports while noting integrated supply chains and drug price headwinds affecting the healthcare sector.Jun 8
• The market is under pressure due to the OpenAI debut delay, renewed selling pressure on chipmakers like Micron and Nvidia, and the influence of the Middle East conflict on global inflation.Jun 26